Oligomerization is not essential for growth suppression by p53 in p53-deficient osteosarcoma Saos-2 cells

Chikashi Ishioka, Hideki Shimodaira, Christoph Englert, Akira Shimada, Motonobu Osada, Li Qun Jia, Takao Suzuki, Makio Gamo, Ryunosuke Kanamaru

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

The carboxy-terminal portion of the p53 protein contains the tetramerization domain, and the introduction of multiple missense mutations in this domain disrupts the formation of p53 tetramers, resulting in the production of dimeric or monomeric forms of p53. It has recently been shown that a single missense or nonsense mutation in this domain affects the functional properties of p53 both in yeast and in mammalian cells. In this study, we tested the oligomerization of p53 with mutations in the oligomerization domain, when expressed in a human osteosarcoma cell line, Saos-2, in vivo. We found that single point mutations, including two missense and two nonsense mutations, in the α-helix of the oligomerization domain disrupted the oligomerization of p53, but that p53 still retained its ability to inhibit colony formation of cells to some degree. These results suggest that oligomerization and the carboxy-terminal basic domain are not prerequisite for p53-dependent tumor suppression, and this may explain why few of the tumor-derived p53 mutations that have been examined so far are carboxy-terminal mutations.

Original languageEnglish
Pages (from-to)54-60
Number of pages7
JournalBiochemical and Biophysical Research Communications
Volume232
Issue number1
DOIs
Publication statusPublished - Mar 6 1997
Externally publishedYes

Fingerprint

Oligomerization
Osteosarcoma
Nonsense Codon
Missense Mutation
Mutation
Growth
Cells
Tumors
Point Mutation
Neoplasms
Yeasts
Cell Line
Yeast
Proteins

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Oligomerization is not essential for growth suppression by p53 in p53-deficient osteosarcoma Saos-2 cells. / Ishioka, Chikashi; Shimodaira, Hideki; Englert, Christoph; Shimada, Akira; Osada, Motonobu; Jia, Li Qun; Suzuki, Takao; Gamo, Makio; Kanamaru, Ryunosuke.

In: Biochemical and Biophysical Research Communications, Vol. 232, No. 1, 06.03.1997, p. 54-60.

Research output: Contribution to journalArticle

Ishioka, Chikashi ; Shimodaira, Hideki ; Englert, Christoph ; Shimada, Akira ; Osada, Motonobu ; Jia, Li Qun ; Suzuki, Takao ; Gamo, Makio ; Kanamaru, Ryunosuke. / Oligomerization is not essential for growth suppression by p53 in p53-deficient osteosarcoma Saos-2 cells. In: Biochemical and Biophysical Research Communications. 1997 ; Vol. 232, No. 1. pp. 54-60.
@article{559fd8dcdf8f424b9d9c9895c8cca7be,
title = "Oligomerization is not essential for growth suppression by p53 in p53-deficient osteosarcoma Saos-2 cells",
abstract = "The carboxy-terminal portion of the p53 protein contains the tetramerization domain, and the introduction of multiple missense mutations in this domain disrupts the formation of p53 tetramers, resulting in the production of dimeric or monomeric forms of p53. It has recently been shown that a single missense or nonsense mutation in this domain affects the functional properties of p53 both in yeast and in mammalian cells. In this study, we tested the oligomerization of p53 with mutations in the oligomerization domain, when expressed in a human osteosarcoma cell line, Saos-2, in vivo. We found that single point mutations, including two missense and two nonsense mutations, in the α-helix of the oligomerization domain disrupted the oligomerization of p53, but that p53 still retained its ability to inhibit colony formation of cells to some degree. These results suggest that oligomerization and the carboxy-terminal basic domain are not prerequisite for p53-dependent tumor suppression, and this may explain why few of the tumor-derived p53 mutations that have been examined so far are carboxy-terminal mutations.",
author = "Chikashi Ishioka and Hideki Shimodaira and Christoph Englert and Akira Shimada and Motonobu Osada and Jia, {Li Qun} and Takao Suzuki and Makio Gamo and Ryunosuke Kanamaru",
year = "1997",
month = "3",
day = "6",
doi = "10.1006/bbrc.1997.6216",
language = "English",
volume = "232",
pages = "54--60",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Oligomerization is not essential for growth suppression by p53 in p53-deficient osteosarcoma Saos-2 cells

AU - Ishioka, Chikashi

AU - Shimodaira, Hideki

AU - Englert, Christoph

AU - Shimada, Akira

AU - Osada, Motonobu

AU - Jia, Li Qun

AU - Suzuki, Takao

AU - Gamo, Makio

AU - Kanamaru, Ryunosuke

PY - 1997/3/6

Y1 - 1997/3/6

N2 - The carboxy-terminal portion of the p53 protein contains the tetramerization domain, and the introduction of multiple missense mutations in this domain disrupts the formation of p53 tetramers, resulting in the production of dimeric or monomeric forms of p53. It has recently been shown that a single missense or nonsense mutation in this domain affects the functional properties of p53 both in yeast and in mammalian cells. In this study, we tested the oligomerization of p53 with mutations in the oligomerization domain, when expressed in a human osteosarcoma cell line, Saos-2, in vivo. We found that single point mutations, including two missense and two nonsense mutations, in the α-helix of the oligomerization domain disrupted the oligomerization of p53, but that p53 still retained its ability to inhibit colony formation of cells to some degree. These results suggest that oligomerization and the carboxy-terminal basic domain are not prerequisite for p53-dependent tumor suppression, and this may explain why few of the tumor-derived p53 mutations that have been examined so far are carboxy-terminal mutations.

AB - The carboxy-terminal portion of the p53 protein contains the tetramerization domain, and the introduction of multiple missense mutations in this domain disrupts the formation of p53 tetramers, resulting in the production of dimeric or monomeric forms of p53. It has recently been shown that a single missense or nonsense mutation in this domain affects the functional properties of p53 both in yeast and in mammalian cells. In this study, we tested the oligomerization of p53 with mutations in the oligomerization domain, when expressed in a human osteosarcoma cell line, Saos-2, in vivo. We found that single point mutations, including two missense and two nonsense mutations, in the α-helix of the oligomerization domain disrupted the oligomerization of p53, but that p53 still retained its ability to inhibit colony formation of cells to some degree. These results suggest that oligomerization and the carboxy-terminal basic domain are not prerequisite for p53-dependent tumor suppression, and this may explain why few of the tumor-derived p53 mutations that have been examined so far are carboxy-terminal mutations.

UR - http://www.scopus.com/inward/record.url?scp=0031555901&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031555901&partnerID=8YFLogxK

U2 - 10.1006/bbrc.1997.6216

DO - 10.1006/bbrc.1997.6216

M3 - Article

C2 - 9125151

AN - SCOPUS:0031555901

VL - 232

SP - 54

EP - 60

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 1

ER -